title: Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection.
abstract: Using a decision-tree based model, we investigated the cost-effectiveness of several vaccination strategies for household, day care center and nursery/primary school contacts of primary cases of hepatitis A in France. Depending on the age groups vaccinated, the cost per symptomatic case avoided varied between 700 and 1,300 Euro (1 Euro = 0.93 US dollars) for household contacts. Vaccination of contacts in day care centers and schools resulted in cost-savings. However, these findings are contingent on the limited and controversial data available on vaccine protective efficacy. In particular, the question of the relative efficacy of vaccination as compared with the use of immunoglobulins needs further study.
authors.affiliation: CEMKA-EVAL, 43 Boulevard Maréchal Joffre, 92340 Bourg-la-Reine, France. marc.pechevis@cemka.fr
authors.forename: Marc
authors.initials: M
authors.lastname: Péchevis
authors.forename: Babak
authors.initials: B
authors.lastname: Khoshnood
authors.forename: Laurent
authors.initials: L
authors.lastname: Buteau
authors.forename: Isabelle
authors.initials: I
authors.lastname: Durand
authors.forename: Yuliya
authors.initials: Y
authors.lastname: Piquard
authors.forename: Antoine
authors.initials: A
authors.lastname: Lafuma
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002656:Child Day Care Centers; D002675:Child, Preschool; D015331:Cohort Studies; D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D005260:Female; D005602:France / Q000453:epidemiology; D006506:Hepatitis A / Q000191:economics* / Q000517:prevention & control*; D022362:Hepatitis A Vaccines / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D018803:Models, Economic; D010349:Patient Compliance; D012574:Schools
chemical_list: D022362:Hepatitis A Vaccines